Genecast Biotechnology Co.
Latest round
- Series E
Last raised
- Oct 2020
Total raised
- $248M
Investors
- 19
About Genecast Biotechnology Co.
, Ltd. operates as a biotechnology company that develops cancer diagnosis and therapy. It provides DNA testing and gene-based medicine guidance including circulating DNA extraction and diagnosis that can be applied to lung cancer, rectal cancer, esophageal cancer, etc.
Who invested in Genecast Biotechnology Co.
19 investors across 6 rounds
See all investors in Genecast Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genecast Biotechnology Co.
Who invested in Genecast Biotechnology Co.?
Genecast Biotechnology Co. has 19 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genecast Biotechnology Co. raised?
Genecast Biotechnology Co. has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Genecast Biotechnology Co. last raise money?
Genecast Biotechnology Co.'s most recent round on record is a Series E, in Oct 2020.
What does Genecast Biotechnology Co. do?
Genecast Biotechnology Co. is a biotechnology company.
Where is Genecast Biotechnology Co. headquartered?
Genecast Biotechnology Co. is headquartered in Wuxi, China.
Which VCs invest in companies like Genecast Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genecast Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Genecast Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.